ARCHIVES

Biostatistician Thomas Fleming Warns Against Approval of Provenge.

This article is from The Cancer Letter archive.

Vol. 33 No. 17 | May 4, 2007

Download PDF Visit The Full Archive

Related Articles

Interview: A Conversation with Robert Carlson

October 5, 2012

Anti-Estrogen Drug Therapy Reduces Risk of Invasive Breast Cancer In Older Women

July 25, 2008

Coulter And Venture Capital Firm Form Company To Develop B1 Antibody For NHL

April 28, 1995

Clinical Education Program Phase Out Opposed By NCAB Committee

February 14, 1986

FOLFOX4 Improved PFS In Colorectal Cancer

April 25, 2008

ACCC Statement, ASCO Comments On Health Reform

March 26, 1993